Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Global Regulatory News (JARA)

Share Price Information for Jpmorgan Global (JARA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.60
Bid: 70.00
Ask: 72.60
Change: 0.00 (0.00%)
Spread: 2.60 (3.714%)
Open: 71.60
High: 0.00
Low: 0.00
Prev. Close: 71.60
JARA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Dividend Declaration and Update

23 Apr 2020 15:02

RNS Number : 6975K
JPMorgan Global Core Real Assets Ld
23 April 2020
 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN GLOBAL CORE REAL ASSETS LIMITED

(the "Company" or "JARA")

 

DIVIDEND DECLARATION AND UPDATE

 

 

Legal Entity Identifier: 549300D8JHZTH6GI8F97

Information disclosed in accordance with DTR 6.1.13

 

Second Quarterly Interim Dividend

 

The Directors have declared a second quarterly interim dividend of 0.75p per share, to be paid on 28th May 2020 to shareholders on the register as at the close of business on 1st May 2020. The ex-dividend date will be 30th April 2020. The Company's first quarterly dividend of 0.75 pence per share was paid on 27th February 2020.

 

· As detailed in the Prospectus, the Company is targeting a dividend yield on the Ordinary Shares of 2% to 3%. (on the basis of the Initial Issue Price), in the first 12 months from the date of Initial Admission. Post this second dividend, the Company will have paid 1.5p per share since its 24th September 2019 IPO and remains on track to meet its dividend target.

· The Company has so far invested approximately 40% of the proceeds arising from its IPO and from subsequent share issuance. The current turmoil in financial markets has meant capital has been drawn down slower than originally intended, but we remain on course be in fully invested at or around 12 months from IPO as stated in the Prospectus. Importantly, this does not impact the Company's long term return assumptions and may in fact provide a benefit.

· In the short term, due to the fall in money market rates, the interest income which the Company is receiving on its near cash instruments has declined as rate cuts in response to the coronavirus pandemic have reduced the yields available on these instruments.

· While, in the short term, this means the Company's liquidity is higher than planned, the Manager views this as a net positive as it provides the opportunity to deploy cash into investments at lower prices, and therefore higher yields, providing longer term support to the dividend.

 

These effects mean there is a short term reduction in the income account and, until further capital is drawn into the underlying strategies, the Directors intend to maintain the current level of dividend payments, supplementing the Company's earnings by using the reserves accumulated in the share premium account which, following payment of the second interim dividend, will stand at approximately 1.62 pence per share. The Directors therefore see no immediate threat to the level of quarterly dividends being paid, but they recognise that, in the longer term, their ability to maintain and grow the dividend will depend on the rate at which the fund can invest and in the continuing success of the underlying strategies.

 

In summary, despite current market conditions, with the proposed drawdown profile of the underlying strategies, the Company remains on track to hit full deployment at or around the 12 month point, as outlined in the Prospectus. Importantly, given the growth of JARA and reduction in fees and ongoing costs, we remain comfortably able to achieve the long term target of 4% - 6% income on issue price for the second 12 month period and current market conditions could allow a potentially attractive entry point for the Company's capital to help support the long term total returns of 7% - 9%.

 

In due course, an update will be provided to investors on the progress of the Company's investment portfolio.

 

 

23rd April 2020

 

 

For further information:

 

Alison Vincent

JPMorgan Funds Limited

Company Secretary

 

020 7742 4000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DIVUOVORRKUSUAR
Date   Source Headline
28th Feb 20206:00 pmRNSTotal Voting Rights
18th Feb 20204:51 pmRNSIssue of Equity
12th Feb 20204:48 pmRNSIssue of Equity
11th Feb 20204:07 pmRNSIssue of Equity
5th Feb 20203:20 pmRNSIssue of Equity
31st Jan 20205:00 pmRNSTotal Voting Rights
31st Jan 20203:54 pmRNSIssue of Equity
24th Jan 20204:12 pmRNSIssue of Equity
23rd Jan 202011:30 amRNSDividend Declaration
22nd Jan 20204:35 pmRNSIssue of Equity
20th Jan 20202:53 pmRNSDirector/PDMR Shareholding
15th Jan 20204:10 pmRNSIssue of Equity
9th Jan 20204:16 pmRNSIssue of Equity
7th Jan 20202:50 pmRNSIssue of Equity
6th Jan 20203:08 pmRNSIssue of Equity
6th Jan 20202:36 pmRNSIssue of Equity
31st Dec 20191:00 pmRNSTotal Voting Rights
19th Dec 20194:27 pmRNSIssue of Equity - Replacement
19th Dec 20193:44 pmRNSIssue of Equity
17th Dec 201912:33 pmRNSIssue of Shares
13th Dec 20192:23 pmRNSIssue of Shares
12th Dec 20194:15 pmRNSIssue of Shares
9th Dec 20193:13 pmRNSIssue of Shares
9th Dec 201910:53 amRNSNet Asset Value and Update
29th Nov 20195:30 pmRNSTotal Voting Rights
27th Nov 20191:26 pmRNSIssue of Equity
22nd Nov 20193:40 pmRNSIssue of Equity
20th Nov 20193:08 pmRNSIssue of Equity
19th Nov 20193:36 pmRNSIssue of Equity
18th Nov 20192:50 pmRNSIssue of Equity
15th Nov 20192:02 pmRNSIssue of Equity
13th Nov 20192:10 pmRNSIssue of Equity
12th Nov 20192:12 pmRNSIssue of Equity
11th Nov 20192:30 pmRNSIssue of Equity
31st Oct 20195:29 pmRNSTotal Voting Rights
29th Oct 20194:28 pmRNSIssue of Equity
29th Oct 201912:00 pmRNSAppointment of Corporate Broker
29th Oct 20197:00 amRNSUpdate on Investment Progress
28th Oct 20194:40 pmRNSIssue of Equity
25th Oct 201911:08 amRNSIssue of Equity
22nd Oct 20193:53 pmRNSIssue of Equity
15th Oct 201911:43 amRNSHolding(s) in Company
11th Oct 201910:33 amRNSHolding(s) in Company
25th Sep 201912:31 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.